The opening of this new headquarters of IFIMAV represents a further step in the line of becoming an Institute of Health Research accredited by the Institute of Health Carlos III. The Institute of Training and Research Marqués de Valdecilla opens its new headquarters next to the Cantabria Residence At the activity level, IFIMAV has 28 research groups composed of researchers, collaborators and technical staff, belonging to the Cantabrian Health Service (Hospital Universitario Marqués de Valdecilla, Hospital Sierrallana, Laredo Hospital) and the University of Cantabria (UC). These professionals are distributed in six different areas: Cancer, Neuroscience, Transplantation of organs and tissues and new therapies, Metabolism, aging and habits of life, Infection in Immunity and a Transversal Area. Research: The groups are classified as consolidated (13 groups), clinical associates (8 groups), emerging (5 groups), and transversal (2 groups), and are composed mainly by staff from the University Hospital Marqués de Valdecilla and the Faculty of Medicine of the UC. These groups are made up of 413 members, 58 of them principal researchers. In the last five years they have published more than 1,100 jobs. The number of annual papers is around 250, with an average impact factor of 700. 70% of the original papers are published in first or second quartile journals, that is, with a high degree of relevance among the scientific community. The IFIMAV researchers are integrated into the Consolider (Centrosoma), the Consortiums in support of biomedical research (CIBER) of neurodegenerative diseases (CIBERNed) and mental health. The IFIMAV researchers are integrated into the Consolider (Centrosoma), the Consortiums in support of biomedical research (CIBER) of neurodegenerative diseases (CIBERNed) and mental health (CIBERSAM). The IFIMAV researchers also participate in the various Cooperative Research Thematic Networks (RETICs) of the Carlos III Health Institute, specifically in the Infectious Pathology Network (REIPI), the Cancer Network (RTICC), the Renal Diseases Network (REDINREN) Network of Aging and Fragility RETICEF), Addictive Disorders Network (RTA), Maternal and Child Health and Development Network (SAMID), Biobanks Network and Innovation Network in Health Technology and Materials (ITEMAS). IFIMAV has also been incorporated into a Consortium led by the Carlos III Health Institute and created to support biomedical network research and the consolidation of central clinical research and clinical trials for non-commercial purposes called CAIBER (Support Consortium Biomedical research in network). This inclusion is an undoubted recognition of IFIMAVs capabilities, since it is included among the most recognized research support units in the national scene.